Erythropoiesis-stimulating Agent Use among Patients with Lupus Nephritis Approaching End-stage Renal Disease

OBJECTIVES: Little is known about erythropoiesis-stimulating agents (ESAs) utilization among lupus nephritis (LN) patients with incipient ESRD. We aimed to identify sociodemographic and clinical factors associated with ESA use among incident LN ESRD patients. METHODS: Among all individuals age ≥18 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Puerta, José A, Waikar, Sushrut S, Solomon, Daniel H, Liu, Jun, Alarcón, Graciela S, Winkelmayer, Wolfgang C, Costenbader, Karen H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963515/
https://www.ncbi.nlm.nih.gov/pubmed/24672742
http://dx.doi.org/10.4172/2155-9899.1000179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963515/
https://www.ncbi.nlm.nih.gov/pubmed/24672742
http://dx.doi.org/10.4172/2155-9899.1000179

Ejemplares similares